In the BioHarmony Drug Report Database

"Preview" Icon

Gemfibrozil

Lopid (gemfibrozil) is a small molecule pharmaceutical. Gemfibrozil was first approved as Lopid on 1982-01-01. It is used to treat coronary artery disease, hypercholesterolemia, hyperlipoproteinemias, and hypertriglyceridemia in the USA. The pharmaceutical is active against peroxisome proliferator-activated receptor alpha. In addition, it is known to target solute carrier organic anion transporter family member 2B1, solute carrier organic anion transporter family member 1B1, solute carrier organic anion transporter family member 1B3, and transthyretin.

 

Trade Name

 

Lopid
 

Common Name

 

gemfibrozil
 

ChEMBL ID

 

CHEMBL457
 

Indication

 

coronary artery disease, hypercholesterolemia, hyperlipoproteinemias, hypertriglyceridemia
 

Drug Class

 

Image (chem structure or protein)

Gemfibrozil structure rendering